S.NO AGE SEX ST U DY EYE COMPLAINTS DEFECTIVE VISION PAIN WATERING
PHOTOPHOBIA REDNESS FLOATERS
OC
U
LAR FINDINGS LATERALITY
VIS U AL AC U ITY AT PRESENTATION VIS U AL AC U
ITY AT FINAL VISIT
PATHOLOGY SEVERITY CHRONICITY AGE AT ONSET
ACT
U
AL D
U
RATION OF
SYMPTOMS (DAYS) AT FIRST
PRESENTATION LOCATION INTRAOC U LAR PRESS U RE
ANTERIOR SEGMENT MANIFESTATIONS
SCLERITIS CONJ U NCTIVAL U LCER KERATITIS KERATIC PRECIPITATES
HYPOPYON CELLS FLARE IRIS NOD
U LES LENS STAT US EXTRAOC U LAR M U SCLE INVOLVEMENT
POSTERIOR SEGMENT MANIFESTATIONS
MEDIA
VITREO
U
S CELLS
SNOW BANK SNOW BALLS RETINITIS VASC
U LITIS VITREO U S OPACITIES/MEMBRRANE NEOVASC U LARISATION
OPTIC NERVE EDEMA MAC
U
LAR EDEMA OTHERS
EXTRAOC U LAR MANIFESTATIONS RECC U RENT ORAL U LCERS GENITAL U LCERS
ARTHRITIS SKIN LESIONS THRMBOPHLEBITIS CNS INVOLVEMENT
OTHERS
PAST TREATMENT O
U TSIDE MEDICATION IF IMM U NOS U PRESSIVE SU RGICAL OTHERS FL U
ORESCEIN ANGIOGRAPHY OPTICAL COHERENCE
TOMOGRAPHY PATHERGY TEST
U
LTRASONOGRAPHY
OTHERS
COMMENTS TREATMENT TOPICAL STEROID ORAL STEROID
POSTERIOR S
U
BTENON
INJECTION STEROID IMM
U
NOS
U
PPRESSIVE
1 23 M 1 1 0 0 0 1 1 3 2/60 2/60 2 3 2 22 365 4 11 0 0 0 0 0 1 1 0 2 0 1 1 0 0 0 1 1 0 0 1 0 1 1 0 0 0 0 0 2 3 1 0 0
FOVEAL ATROPHY, LOSS OF FOVEAL THICKNESS
0 1 0 1
2 0 0 0 0 0 1 3 6/6 6/12 2 1 2 22 365 3 13 0 0 0 0 0 0 0 0 2 0 1 1 0 0 0 1 1 0 0 0 0 1 1 0 0 0 0 0 2 3 1 0 0 0 1 0 1
2 49 M 2 1 1 0 0 1 0 2 6/24 6/24 2 2 2 49 10 1 20 0 0 0 1 0 1 1 0 3 0 1 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 2 3 1 0 0 1 0 0 0
3 19 M 1 1 0 0 0 0 0 3 6/24 6/18 2 2 2 17 730 4 32 0 0 0 0 0 1 1 0 2 0 2 0 0 0 0 1 0 0 0 1 0 1 0 0 0 0 0 0 1 1 0 0 0 1 1 0 1
2 1 0 0 0 0 0 3 6/36 6/36 2 2 2 17 730 4 30 0 0 0 0 0 1 1 0 2 0 2 0 0 0 0 1 0 0 0 1 0 1 0 0 0 0 0 0 1 1 0 0 0 1 1 0 1
4 29 M 1 1 0 0 0 0 0 3 PL-VE PL-VE 2 3 1 29 183 4 56 0 0 0 0 0 0 1 0 1 0 2 1 0 0 0 1 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 1 0 0
2 1 0 0 0 0 0 3 1/2 / 60 1/2 / 60 2 3 1 29 183 4 10 0 0 0 0 0 0 0 0 1 0 1 1 0 0 0 1 1 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0VITREOUS HAEMORRHAGE
HYPER REFLECTIVE LESION AT MACULA, FOVEAL
0 1 0 0
5 13 M 1 1 0 0 1 0 1 3 3/60 6/12 2 3 2 13 7 4 11 0 0 0 1 0 1 1 0 1 0 1 1 0 1 1 1 1 0 0 1 0 1 1 0 1 0 0 0 0 0 0 0 0
TOTAL LOSS OF VESSELS, CNPs, FOVEA NOT MADE OUT
1 1 0 1
2 1 0 0 1 0 1 3 3/60 6/6 2 3 2 13 7 4 18 0 0 0 1 0 1 1 0 1 0 1 1 0 1 1 1 1 0 0 0 0 1 1 0 1 0 0 0 0 0 0 0 0 1 1 0 1
6 22 M 1 1 0 0 0 1 0 3 6/6 6/6 2 2 2 21 365 4 26 0 0 0 1 0 1 1 0 1 0 1 1 0 0 0 0 1 0 0 0 0 1 0 0 1 0 0 0 1 1 0 0 0 1 1 0 0
2 1 0 0 0 1 0 3 6/6 6/6 2 2 2 21 365 4 39 0 0 0 1 0 1 1 0 1 0 1 1 0 0 0 0 1 0 0 0 0 1 0 0 1 0 0 0 1 1 0 0 0 1 1 0 0
7 24 M 1 1 1 0 0 1 0 3 6/6 HM+ 2 1 2 21 1095 4 6 0 0 0 1 0 1 1 0 1 0 1 1 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 1 3 6 0 0 NORMAL THIN ERM 0 1 1 1
2 1 0 0 0 0 0 3 6/6 6/60 2 3 2 21 1095 4 6 0 0 0 1 0 1 1 0 1 0 1 1 0 0 1 1 1 0 0 0 0 1 1 0 0 0 0 0 1 3 6 0 0
EARLY BLOCKED FLUORESCENE WITH LATE STAINING OF SUBRETINAL THIN ERM. FOVEAL ATROPHY
8 24 M 1 0 0 0 0 0 0 3 6/6 6/6 2 2 2 24 10 4 6 0 0 0 1 0 1 1 0 1 0 1 1 0 0 0 1 1 0 0 1 0 1 1 0 0 0 0 0 1 1 0 0 0 1 1 1 1
2 1 1 0 0 1 0 3 HM+ 6/60 2 3 2 24 10 4 6 0 0 0 1 0 1 1 0 1 0 1 1 0 0 0 1 1 0 0 1 0 1 1 0 0 0 0 0 1 1 0 0 0 1 1 1 1
9 35 M 2 1 1 1 1 1 1 2 6/9 6/24 2 3 1 35 10 4 10 0 0 0 1 1 1 1 0 4 0 1 1 0 0 0 1 0 0 0 1 0 1 1 1 0 0 0 0 1 1 0 0 0
SEROUS DETACHMENT AT THE MACULA
1 1 1 0
10 38 M 1 1 0 0 0 0 1 3 6/24 6/18 2 2 2 33 1825 4 12 0 0 0 1 0 1 1 0 1 0 1 1 0 0 0 1 0 0 0 1 0 1 1 0 1 0 0 0 1 1 0 0 0 1 1 1 1
2 1 0 0 0 0 1 3 6/6 6/12 2 2 2 33 1825 4 13 0 0 0 1 0 0 0 0 1 0 1 1 0 0 0 1 0 0 0 1 0 1 1 0 1 0 0 0 1 1 0 0 0 1 1 1 1
11 34 M 1 1 1 0 0 1 0 1 6/60 5/60 2 2 2 34 180 4 16 0 0 0 1 1 1 1 0 1 0 1 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 2 1 0 0 0 MILD MACULAR EDEMA 1 1 1 0
12 30 M 1 1 0 0 0 0 0 3 1/2 / 60 1/2 / 60 2 3 2 27 1095 4 24 0 0 0 1 1 1 1 0 2 0 2 1 0 0 0 0 1 0 0 0 0 1 0 1 0 0 0 0 2 3 4 0 0
?VASCUL ITIS WITH VH
1 1 0 1
2 0 0 0 0 0 0 3 6/24 6/18 2 1 2 27 1095 4 15 0 0 0 0 0 1 1 0 3 0 2 1 0 0 0 0 1 0 0 0 0 1 0 1 0 0 0 0 2 3 4 0 0 0 1 0 1
13 31 M 2 1 1 0 0 1 0 2 6/6 6/6 2 1 2 30 240 2 11 0 0 0 0 0 0 0 0 1 0 1 1 0 0 0 0 0 0 0 0 0 1 1 1 0 0 1 0 2 3 1,7 0 0
RE .LSS OF FOVEAL THICKNESS AND CONTOUR, POST CSR
0 1 0 1
14 33 F 1 0 1 0 0 1 0 3 6/6 6/6 2 2 2 33 30 4 18 0 0 0 1 0 1 1 0 1 0 1 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 1 0 0 0
POSTERI OR SCLERITIS
1 1 0 1
2 0 1 0 0 1 0 3 6/6 6/6 2 2 2 33 30 4 20 1 0 0 1 0 1 1 0 1 0 1 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 1 0 0 0 1 1 0 1
15 44 M 1 0 0 0 0 0 0 3 6/6 6/6 2 1 2 44 7 4 35 0 0 0 0 0 1 1 0 1 0 1 1 0 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0
2 1 0 0 0 0 0 3 4/60 6/6 2 3 2 44 7 4 42 0 0 0 1 0 1 1 0 1 0 1 1 0 0 1 1 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0
16 34 M 1 1 0 0 0 0 1 3 6/18 6/6 2 2 2 33 365 4 10 0 0 0 0 0 0 0 0 1 0 1 1 0 0 0 0 0 0 0 0 0 1 1 1 0 0 0 0 2 1 0 0 0 1 1 0 0
17 31 M 1 1 0 0 0 0 1 3 6/6 6/6 2 2 2 31 547 4 17 0 0 0 1 0 1 1 0 1 0 1 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 2 3 5 0 0 1 1 0 1
2 1 0 0 0 0 1 3 6/6 6/6 2 2 2 31 547 4 20 0 0 0 0 0 1 1 0 1 0 1 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 2 3 5 0 0 1 1 0 1
18 28 M 1 1 1 0 0 1 0 3 6/18 6/18 2 2 2 28 365 4 20 0 0 0 1 0 0 0 0 1 0 1 1 0 0 0 1 1 0 0 0 0 1 0 1 0 0 0 0 2 3 1 0 0 1 1 1 1
2 1 1 0 0 1 0 3 6/9 6/9 2 2 2 28 365 4 19 0 0 0 1 0 0 0 0 1 0 1 1 0 0 0 1 0 0 0 0 0 1 0 1 0 0 0 0 2 3 1 0 0 1 1 1 1
19 44 M 1 1 0 0 1 0 0 3 6/9 6/9 2 1 2 44 60 4 11 0 0 0 0 0 1 1 0 1 0 1 0 0 0 0 0 1 0 0 1 0 1 0 1 0 0 0 0 2 3 4,6 0METFORMIN TAB 0 0 0 0
2 0 0 0 0 0 0 3 6/6 6/6 2 1 2 44 60 4 13 0 0 0 0 0 1 1 0 1 0 1 0 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 2 3 0 0METFORMIN TAB 0 0 0 0
20 40 M 1 1 0 0 0 0 0 3 HM+ FCF 2 3 2 36 1460 4 14 0 0 0 0 0 1 1 0 2 0 2 1 0 0 0 1 0 0 0 0 0 1 1 0 0 0 0 0 2 3 5 0 0 1 1 0 1
2 1 0 0 0 0 0 3 6/18 6/6 2 3 2 36 1460 4 14 0 0 0 0 0 1 1 0 3 0 2 1 0 0 0 1 0 0 0 0 0 1 1 0 0 0 0 0 2 3 5 0 0 CNP AREAS 1 1 0 1
21 25 M 1 1 0 0 0 0 0 3 PL+VE 1/60 2 3 2 20 1825 4 8 0 0 0 1 0 1 1 0 2 0 2 1 0 0 0 1 0 0 0 0 0 1 1 1 0 0 0 0 1 3 4,5 0 0 0 1 0 1
2 1 0 0 0 0 0 3 1/60 1/60 2 3 2 20 1825 4 7 0 0 0 1 0 1 1 0 3 0 1 1 0 0 0 1 0 0 0 0 0 1 1 1 0 0 0 0 1 3 4,5 0 0 0 1 0 1
22 26 M 1 1 0 0 0 0 0 3 1/60 1/60 2 3 2 20 2190 4 17 0 0 0 1 0 1 1 0 1 0 1 1 0 0 1 1 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0ACTIVE VASCULITIS 0 1 0 1
2 1 0 0 0 0 0 3 6/6 6/6 2 3 2 20 2190 4 18 0 0 0 0 0 0 0 0 1 0 1 1 0 0 1 1 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0ACTIVE VASCULITIS 0 1 0 1
23 33 M 1 1 0 0 0 1 0 3 5/60 6/24 2 3 2 33 25 4 17 0 0 0 1 0 1 1 0 3 0 1 1 0 0 0 1 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 1 0 1
2 1 0 0 0 0 0 3 1/60 6/36 2 3 2 33 25 4 24 0 0 0 1 1 1 1 0 3 0 1 1 0 0 0 1 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 1 1 0 1
2 1 0 0 0 0 0 3 6/60 6/9 2 3 2 16 3650 4 9 0 0 0 1 1 1 1 0 2 0 2 1 0 0 0 1 1 0 1 1 0 1 1 0 0 0 0 0 0 0 0 0 0 CME 1 1 1 0
25 18 M 1 1 0 0 0 0 0 3 1/60 FCF 2 3 2 15 1095 4 30 0 0 0 1 0 1 1 0 2 0 2 1 0 0 0 1 1 0 0 1 0 1 1 0 0 0 0 0 2 3 5 0 0 1 1 1 1
2 1 0 0 0 0 0 3 PL-VE PL-VE 2 3 2 15 1095 4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0
26 14 M 1 1 0 1 1 1 1 3 3/60 6/9 2 3 2 14 365 4 32 0 0 0 1 1 1 1 0 1 0 1 1 1 1 1 1 1 0 1 1 0 0 0 1 0 0 0 0 1 1 0 0 0 1 1 0 1
2 1 0 1 1 1 1 3 6/9 6/9 2 3 2 14 365 4 34 0 0 0 1 0 1 1 0 1 0 1 1 1 1 1 1 1 0 1 1 0 0 0 1 0 0 0 0 1 1 0 0 0 1 1 0 1
27 22 M 1 0 0 0 0 0 0 3 6/6 6/6 2 3 2 22 730 4 18 0 0 0 1 0 1 1 0 1 0 1 1 1 1 0 1 0 0 1 0 0 1 1 1 0 0 0 0 1 1 0 0 0 1 1 1 1
2 1 0 0 1 0 0 3 6/6 6/18 2 3 2 22 730 4 16 0 0 0 1 0 1 1 0 1 0 1 1 1 1 1 1 0 0 1 0 0 1 1 1 0 0 0 0 1 1 0 0 0 1 1 1 1
28 19 F 1 0 0 0 0 0 1 3 6/6 PL+VE 2 3 2 19 90 4 14 0 0 0 1 1 1 1 1 1 0 2 1 1 1 1 1 1 0 1 1 0 1 1 0 0 0 0 0 1 3 6 0 0 1 1 1 1
2 0 0 0 1 1 0 3 6/6 5/60 2 3 2 19 90 4 12 0 0 0 1 1 1 1 0 1 0 2 1 0 0 1 1 1 0 1 1 0 1 1 0 0 0 0 0 1 3 6 0 0 1 1 1 1
29 23 M 1 1 1 0 0 1 0 3 PL-VE N/A 2 3 2 21 730 4 N/A 0 0 0 0 0 1 1 0 1 0 2 1 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 1 3 1,2 0 0 0 1 0 1
2 1 1 0 0 0 0 3 4/60 1/2 / 60 2 3 2 21 730 4 13 0 0 0 1 1 1 1 0 2 0 2 1 0 1 1 0 0 0 0 0 0 1 0 0 0 0 0 0 1 3 1,2 0 0 1 1 1 1
IMM
U
N
U
PRESSIVE(SPECIFIC) SURGICAL OTHERS
COMPLICATIONS SYNECHIAE
RU
BEOSIS
CATARACT
VITREO
U
S HAEMORRHAGE GLAU
COMA
OPTIC ATROPHY
NEOVASC
U
LARISATION
MAC
U
LAR EDEMA
MAC
U
LAR DEGENERATION MAC
U
LAR HOLE
EPIRETINAL MEMBRANE VENO
U
S OCCL
U
SION
RETINAL TEAR
RETINAL DETACHMENT
PTHISIS B
U
LBI
END STAGE DISEASE
OTHERS
1 0 0 0 0 1 0 0 1 0 1 1 0 1 0 0 0 0 0 0
1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
5 PRP,AADI 0 0 0 1 0 4 0 0 1 0 0 0 0 0 0 0 0 0
5 PRP,AADI 0 0 0 1 0 4 0 0 1 0 0 0 0 0 0 0 0 0
0 0 0 1,2 1 0 1 3 0 0 0 0 0 0 0 0 0 0 1 0
0 PRP 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0
1,6 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0
1,6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0
6 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0
1,6 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 0 0
1,6 0 0 2 0 0 0 0 0 0 1 1 0 1 0 0 0 0 0 0
0
VITREOUS TAP, INTRAVITREAL V + C + D, CORE VITRECTOMY
0 0 0 0 0 0 0 0 1 0 0 1 0 0 1 0 0 0
1 0 0 0 0 0 0 2 0 0 1 0 0 1 0 0 0 0 0 0
1 0 0 0 0 0 0 2 0 0 1 0 0 1 0 0 0 0 0 0
0 0 0 2 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0
4 0 0 2 0 1 0 4 0 0 0 0 0 0 0 0 0 0 0 0
4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
1,7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0CSR OTHER EYE
1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0
BRIMONIDINE FOR GLACUOMA
0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0
0 0
BRIMONIDINE FOR GLACUOMA
0 0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0ALLERGY TO CICLOSPORINE
7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0ALLERGY TO CICLOSPORINE
1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0
1 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0
0 0
CAP MACUGOLD(V ITAMIN A)
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 CSR
0 0
CAP MACUGODL(V ITAMIN A)
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
1 PHACO 0 0 0 1 0 0 1 0 0 1 0 1 0 0 0 0 1 0
1 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0
1 SICS 0 0 0 1 0 0 0 0 0 1 0 0 0 0 0 0 0 0
1 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 0 0 1 0
1 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0 0 0 0 0
1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
1 0GLUCOMOL FOR IOP RISE 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0
1 0GLUCOMOL FOR IOP RISE 2 0 0 1 0 0 0 0 1 0 1 0 0 0 0 0 0
4 0 0 2 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0
1, 4 TRAB,PHACO COMBIGAN, DORZOX T 2 0 1 0 4 0 0 1 0 0 1 0 0 0 0 0 0
0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0
1,4 0 0 2 0 0 0 2 0 0 1 0 0 1 0 0 1 0 0 0
0 0 0 0 2 0 0 1 0 0 1 0 0 0 0 0 0
1 0 0 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
1,2,6,7 0 0 2 0 1 0 0 1 0 1 0 0 1 0 0 0 0 1 0
0 0 0 0 1 0 0 0 0 1 0 0 0 0 0 0 0 0 0
1,2 ENUCLEATION 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0
1,2 PHACO 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0